Industry: Consumer Goods
Published Date: 2024-01-18
Pages: 106 Pages
Report ld: 2314767
Request Sample
Customized Report
Nicotinamide Ribose Supplement Market Size(US$)

CAGR 2024-2030
6.8%
Market Size,2030
USD 566.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Nicotinamide Ribose Supplement market was valued at US$ 361 million in 2023 and is anticipated to reach US$ 566.9 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
North American market for Nicotinamide Ribose Supplement is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nicotinamide Ribose Supplement is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nicotinamide Ribose Supplement include Jarrow, Codeage, Tru Niagen, The major vendors covered:, Chroma Dex, Elysium Health, Natural Nutra, Thorne and Zhejiang Jiahua Pharmchemical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nicotinamide Ribose Supplement, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Ribose Supplement.
MARKET SEGMENTATION
REPORT SCOPE
The Nicotinamide Ribose Supplement market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nicotinamide Ribose Supplement market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nicotinamide Ribose Supplement manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nicotinamide Ribose Supplement manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nicotinamide Ribose Supplement in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Nicotinamide Ribose Supplement Market Overview
1.1 Product Overview and Scope of Nicotinamide Ribose Supplement
1.2 Nicotinamide Ribose Supplement Segment by Type
1.2.1 Global Nicotinamide Ribose Supplement Market Value Comparison by Type (2024-2030)
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.2.4 Others
1.3 Nicotinamide Ribose Supplement Segment by Application
1.3.1 Global Nicotinamide Ribose Supplement Market Value by Application: (2024-2030)
1.3.2 Food Industry
1.3.3 Pharmaceutical Industry
1.3.4 Others
1.4 Global Nicotinamide Ribose Supplement Market Size Estimates and Forecasts
1.4.1 Global Nicotinamide Ribose Supplement Revenue 2019-2030
1.4.2 Global Nicotinamide Ribose Supplement Sales 2019-2030
1.4.3 Global Nicotinamide Ribose Supplement Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nicotinamide Ribose Supplement Market Competition by Manufacturers
2.1 Global Nicotinamide Ribose Supplement Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nicotinamide Ribose Supplement Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nicotinamide Ribose Supplement Average Price by Manufacturers (2019-2024)
2.4 Global Nicotinamide Ribose Supplement Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nicotinamide Ribose Supplement, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nicotinamide Ribose Supplement, Product Type & Application
2.7 Nicotinamide Ribose Supplement Market Competitive Situation and Trends
2.7.1 Nicotinamide Ribose Supplement Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nicotinamide Ribose Supplement Players Market Share by Revenue
2.7.3 Global Nicotinamide Ribose Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nicotinamide Ribose Supplement Retrospective Market Scenario by Region
3.1 Global Nicotinamide Ribose Supplement Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nicotinamide Ribose Supplement Global Nicotinamide Ribose Supplement Sales by Region: 2019-2030
3.2.1 Global Nicotinamide Ribose Supplement Sales by Region: 2019-2024
3.2.2 Global Nicotinamide Ribose Supplement Sales by Region: 2025-2030
3.3 Global Nicotinamide Ribose Supplement Global Nicotinamide Ribose Supplement Revenue by Region: 2019-2030
3.3.1 Global Nicotinamide Ribose Supplement Revenue by Region: 2019-2024
3.3.2 Global Nicotinamide Ribose Supplement Revenue by Region: 2025-2030
3.4 North America Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.4.1 North America Nicotinamide Ribose Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nicotinamide Ribose Supplement Sales by Country (2019-2030)
3.4.3 North America Nicotinamide Ribose Supplement Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.5.1 Europe Nicotinamide Ribose Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nicotinamide Ribose Supplement Sales by Country (2019-2030)
3.5.3 Europe Nicotinamide Ribose Supplement Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.6.1 Asia Pacific Nicotinamide Ribose Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nicotinamide Ribose Supplement Sales by Country (2019-2030)
3.6.3 Asia Pacific Nicotinamide Ribose Supplement Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.7.1 Latin America Nicotinamide Ribose Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nicotinamide Ribose Supplement Sales by Country (2019-2030)
3.7.3 Latin America Nicotinamide Ribose Supplement Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nicotinamide Ribose Supplement Market Facts & Figures by Country
3.8.1 Middle East and Africa Nicotinamide Ribose Supplement Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nicotinamide Ribose Supplement Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nicotinamide Ribose Supplement Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nicotinamide Ribose Supplement Sales by Type (2019-2030)
4.1.1 Global Nicotinamide Ribose Supplement Sales by Type (2019-2024)
4.1.2 Global Nicotinamide Ribose Supplement Sales by Type (2025-2030)
4.1.3 Global Nicotinamide Ribose Supplement Sales Market Share by Type (2019-2030)
4.2 Global Nicotinamide Ribose Supplement Revenue by Type (2019-2030)
4.2.1 Global Nicotinamide Ribose Supplement Revenue by Type (2019-2024)
4.2.2 Global Nicotinamide Ribose Supplement Revenue by Type (2025-2030)
4.2.3 Global Nicotinamide Ribose Supplement Revenue Market Share by Type (2019-2030)
4.3 Global Nicotinamide Ribose Supplement Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nicotinamide Ribose Supplement Sales by Application (2019-2030)
5.1.1 Global Nicotinamide Ribose Supplement Sales by Application (2019-2024)
5.1.2 Global Nicotinamide Ribose Supplement Sales by Application (2025-2030)
5.1.3 Global Nicotinamide Ribose Supplement Sales Market Share by Application (2019-2030)
5.2 Global Nicotinamide Ribose Supplement Revenue by Application (2019-2030)
5.2.1 Global Nicotinamide Ribose Supplement Revenue by Application (2019-2024)
5.2.2 Global Nicotinamide Ribose Supplement Revenue by Application (2025-2030)
5.2.3 Global Nicotinamide Ribose Supplement Revenue Market Share by Application (2019-2030)
5.3 Global Nicotinamide Ribose Supplement Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Jarrow
6.1.1 Jarrow Corporation Information
6.1.2 Jarrow Description and Business Overview
6.1.3 Jarrow Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Jarrow Nicotinamide Ribose Supplement Product Portfolio
6.1.5 Jarrow Recent Developments/Updates
6.2 Codeage
6.2.1 Codeage Corporation Information
6.2.2 Codeage Description and Business Overview
6.2.3 Codeage Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Codeage Nicotinamide Ribose Supplement Product Portfolio
6.2.5 Codeage Recent Developments/Updates
6.3 Tru Niagen
6.3.1 Tru Niagen Corporation Information
6.3.2 Tru Niagen Description and Business Overview
6.3.3 Tru Niagen Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tru Niagen Nicotinamide Ribose Supplement Product Portfolio
6.3.5 Tru Niagen Recent Developments/Updates
6.4 The major vendors covered:
6.4.1 The major vendors covered: Corporation Information
6.4.2 The major vendors covered: Description and Business Overview
6.4.3 The major vendors covered: Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 The major vendors covered: Nicotinamide Ribose Supplement Product Portfolio
6.4.5 The major vendors covered: Recent Developments/Updates
6.5 Chroma Dex
6.5.1 Chroma Dex Corporation Information
6.5.2 Chroma Dex Description and Business Overview
6.5.3 Chroma Dex Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Chroma Dex Nicotinamide Ribose Supplement Product Portfolio
6.5.5 Chroma Dex Recent Developments/Updates
6.6 Elysium Health
6.6.1 Elysium Health Corporation Information
6.6.2 Elysium Health Description and Business Overview
6.6.3 Elysium Health Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elysium Health Nicotinamide Ribose Supplement Product Portfolio
6.6.5 Elysium Health Recent Developments/Updates
6.7 Natural Nutra
6.6.1 Natural Nutra Corporation Information
6.6.2 Natural Nutra Description and Business Overview
6.6.3 Natural Nutra Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Natural Nutra Nicotinamide Ribose Supplement Product Portfolio
6.7.5 Natural Nutra Recent Developments/Updates
6.8 Thorne
6.8.1 Thorne Corporation Information
6.8.2 Thorne Description and Business Overview
6.8.3 Thorne Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thorne Nicotinamide Ribose Supplement Product Portfolio
6.8.5 Thorne Recent Developments/Updates
6.9 Zhejiang Jiahua Pharmchemical
6.9.1 Zhejiang Jiahua Pharmchemical Corporation Information
6.9.2 Zhejiang Jiahua Pharmchemical Description and Business Overview
6.9.3 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose Supplement Product Portfolio
6.9.5 Zhejiang Jiahua Pharmchemical Recent Developments/Updates
6.10 Shenzhen Longgesheng Technology
6.10.1 Shenzhen Longgesheng Technology Corporation Information
6.10.2 Shenzhen Longgesheng Technology Description and Business Overview
6.10.3 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shenzhen Longgesheng Technology Nicotinamide Ribose Supplement Product Portfolio
6.10.5 Shenzhen Longgesheng Technology Recent Developments/Updates
6.11 Bontac Bio-engineering
6.11.1 Bontac Bio-engineering Corporation Information
6.11.2 Bontac Bio-engineering Nicotinamide Ribose Supplement Description and Business Overview
6.11.3 Bontac Bio-engineering Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Bontac Bio-engineering Nicotinamide Ribose Supplement Product Portfolio
6.11.5 Bontac Bio-engineering Recent Developments/Updates
6.12 Springtide
6.12.1 Springtide Corporation Information
6.12.2 Springtide Nicotinamide Ribose Supplement Description and Business Overview
6.12.3 Springtide Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Springtide Nicotinamide Ribose Supplement Product Portfolio
6.12.5 Springtide Recent Developments/Updates
6.13 Solaray
6.13.1 Solaray Corporation Information
6.13.2 Solaray Nicotinamide Ribose Supplement Description and Business Overview
6.13.3 Solaray Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Solaray Nicotinamide Ribose Supplement Product Portfolio
6.13.5 Solaray Recent Developments/Updates
6.14 Life Extension
6.14.1 Life Extension Corporation Information
6.14.2 Life Extension Nicotinamide Ribose Supplement Description and Business Overview
6.14.3 Life Extension Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Life Extension Nicotinamide Ribose Supplement Product Portfolio
6.14.5 Life Extension Recent Developments/Updates
6.15 ChromaDex Corporation
6.15.1 ChromaDex Corporation Corporation Information
6.15.2 ChromaDex Corporation Nicotinamide Ribose Supplement Description and Business Overview
6.15.3 ChromaDex Corporation Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.15.4 ChromaDex Corporation Nicotinamide Ribose Supplement Product Portfolio
6.15.5 ChromaDex Corporation Recent Developments/Updates
6.16 Thorne Research
6.16.1 Thorne Research Corporation Information
6.16.2 Thorne Research Nicotinamide Ribose Supplement Description and Business Overview
6.16.3 Thorne Research Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Thorne Research Nicotinamide Ribose Supplement Product Portfolio
6.16.5 Thorne Research Recent Developments/Updates
6.17 Tesseract Medical Research
6.17.1 Tesseract Medical Research Corporation Information
6.17.2 Tesseract Medical Research Nicotinamide Ribose Supplement Description and Business Overview
6.17.3 Tesseract Medical Research Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Tesseract Medical Research Nicotinamide Ribose Supplement Product Portfolio
6.17.5 Tesseract Medical Research Recent Developments/Updates
6.18 Biotrend Chemikalien
6.18.1 Biotrend Chemikalien Corporation Information
6.18.2 Biotrend Chemikalien Nicotinamide Ribose Supplement Description and Business Overview
6.18.3 Biotrend Chemikalien Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Biotrend Chemikalien Nicotinamide Ribose Supplement Product Portfolio
6.18.5 Biotrend Chemikalien Recent Developments/Updates
6.19 Vitacost.com
6.19.1 Vitacost.com Corporation Information
6.19.2 Vitacost.com Nicotinamide Ribose Supplement Description and Business Overview
6.19.3 Vitacost.com Nicotinamide Ribose Supplement Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Vitacost.com Nicotinamide Ribose Supplement Product Portfolio
6.19.5 Vitacost.com Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nicotinamide Ribose Supplement Industry Chain Analysis
7.2 Nicotinamide Ribose Supplement Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nicotinamide Ribose Supplement Production Mode & Process
7.4 Nicotinamide Ribose Supplement Sales and Marketing
7.4.1 Nicotinamide Ribose Supplement Sales Channels
7.4.2 Nicotinamide Ribose Supplement Distributors
7.5 Nicotinamide Ribose Supplement Customers
8 Nicotinamide Ribose Supplement Market Dynamics
8.1 Nicotinamide Ribose Supplement Industry Trends
8.2 Nicotinamide Ribose Supplement Market Drivers
8.3 Nicotinamide Ribose Supplement Market Challenges
8.4 Nicotinamide Ribose Supplement Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 153
USD 3950.00
(Single User License)
The global Nicotinamide Ribose Supplement market was valued at US$ 430 million in 2025 and is anticipated to reach US$ 677 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-04-19
Pages: 132
USD 2900.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-17
Pages: 179
USD 4900.00
(Single User License)
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 102
USD 4250.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-01-31
Pages: 136
USD 3950.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-01-31
Pages: 102
USD 2900.00
(Single User License)
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published Date: 2024-04-09
Pages: 114
USD 4900.00
(Single User License)
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 430 million in 2025 and is projected to reach US$ 677 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 153
The global Nicotinamide Ribose Supplement market was valued at US$ 430 million in 2025 and is anticipated to reach US$ 677 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-04-19
Pages: 132
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 405 million in 2024 to US$ 638 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-17
Pages: 179
The global Nicotinamide Ribose Supplement market size was US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 102
The global market for Nicotinamide Ribose Supplement was estimated to be worth US$ 405 million in 2024 and is forecast to a readjusted size of US$ 638 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-01-31
Pages: 136
The global market for Nicotinamide Ribose Supplement was valued at US$ 405 million in the year 2024 and is projected to reach a revised size of US$ 638 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-01-31
Pages: 102
The global Nicotinamide Ribose Supplement market is projected to grow from US$ 382 million in 2024 to US$ 566.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2024-04-09
Pages: 114
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now